Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.

被引：2
|
作者：
Taylor, Matthew H.
Vogelzang, Nicholas J.
Cohn, Allen Lee
Stepan, Daniel E.
Shumaker, Robert Charles
Dutcus, Corina E.
Guo, Matthew
Schmidt, Emmett V.
Rasco, Drew W.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[3] US Oncol, Rocky Mt Canc Ctr, Denver, CO USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] South Texas Accelerated Res Therapeut, San Antonio, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) a randomised, double-blind, phase 3 trial
    Llovet, Josep M.
    Kudo, Masatoshi
    Merle, Philippe
    Meyer, Tim
    Qin, Shukui
    Ikeda, Masafumi
    Xu, Ruocai
    Edeline, Julien
    Ryoo, Baek-Yeol
    Ren, Zhenggang
    Masi, Gianluca
    Kwiatkowski, Mariusz
    Lim, Ho Yeong
    Kim, Jee Hyun
    Breder, Valeriy
    Kumada, Hiromitsu
    Cheng, Ann-Lii
    Galle, Peter R.
    Kaneko, Shuichi
    Wang, Anran
    Mody, Kalgi
    Dutcus, Corina
    Dubrovsky, Leonid
    Siegel, Abby B.
    Finn, Richard S.
    [J]. LANCET ONCOLOGY, 2023, 24 (12): : 1399 - 1410
  • [32] NEOplus: A phase II study of neoadjuvant lenvatinib and pembrolizumab in resectable mucosal melanoma
    Mao, L.
    Bai, X.
    Wei, X.
    Dai, J.
    Cui, C-L.
    Chi, Z.
    Sheng, X.
    Lian, B.
    Wang, X.
    Bixia, T.
    Si, L.
    Guo, J.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S951 - S951
  • [33] Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
    Makker, Vicky
    Taylor, Matthew H.
    Aghajanian, Carol
    Oaknin, Ana
    Mier, James
    Cohn, Allen L.
    Romeo, Margarita
    Bratos, Raquel
    Brose, Marcia S.
    DiSimone, Christopher
    Messing, Mark
    Stepan, Daniel E.
    Dutcus, Corina E.
    Wu, Jane
    Schmidt, Emmett V.
    Orlowski, Robert
    Sachdev, Pallavi
    Shumaker, Robert
    Casado Herraez, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2981 - 2992
  • [34] A clinical and translational phase II trial of sequential axitinib and carboplatin/paclitaxel in advanced melanoma.
    Algazi, Alain Patrick
    Cha, Edward
    Pampaloni, Miguel H.
    Behr, Spencer
    Cortez, Brandon
    Quiroz, Anteo
    Coakley, Fergus V.
    Liu, Songling
    Daud, Adil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Pembrolizumab Plus Lenvatinib Approved in Advanced Endometrial Carcinoma
    Schuyler, Devon
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 610 - 610
  • [36] Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group
    Urosevic, V
    Chollet, P
    Adenis, A
    Chauvergne, J
    Fargeot, P
    Roche, H
    Kerbrat, P
    Lentz, MA
    Fumoleau, P
    Chevallier, B
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 181 - 182
  • [37] Clinical characteristics predictive of response to pembrolizumab in advanced melanoma.
    Tsai, Katy K.
    Loo, Kimberly
    Khurana, Neharika
    Algazi, Alain Patrick
    Hwang, Jimmy
    Sanchez, Roberto
    Krummel, Matthew
    Rosenblum, Michael
    Tumeh, Paul
    Daud, Adil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
    Weiss, Glen J.
    Waypa, Jordan
    Blaydorn, Lisa
    Coats, Jessica
    McGahey, Kayla
    Sangal, Ashish
    Niu, Jiaxin
    Lynch, Cynthia A.
    Farley, John H.
    Khemka, Vivek
    [J]. BRITISH JOURNAL OF CANCER, 2017, 117 (01) : 33 - 40
  • [39] A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
    Glen J Weiss
    Jordan Waypa
    Lisa Blaydorn
    Jessica Coats
    Kayla McGahey
    Ashish Sangal
    Jiaxin Niu
    Cynthia A Lynch
    John H Farley
    Vivek Khemka
    [J]. British Journal of Cancer, 2017, 117 : 33 - 40
  • [40] KEYNOTE-029: Efficacy and safety of pembrolizumab (pembro) plus ipilimumab (ipi) for advanced melanoma.
    Carlino, Matteo S.
    Atkinson, Victoria
    Cebon, Jonathan S.
    Jameson, Michael B.
    Fitzharris, Bernie M.
    McNeil, Catriona M.
    Hill, Andrew G.
    Ribas, Antoni
    Atkins, Michael B.
    Thompson, John A.
    Hwu, Wen-Jen
    Hodi, F. Stephen
    Menzies, Alexander M.
    Guminski, Alexander David
    Kefford, Richard
    Shu, Xinxin
    Ibrahim, Nageatte
    Moreno, Blanca Hornet
    Long, Georgina V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345